Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages.

D'Andrea G, Nordera G, Pizzolato G, Bolner A, Colavito D, Flaibani R, Leon A.

Neurosci Lett. 2010 Jan 29;469(3):348-51. doi: 10.1016/j.neulet.2009.12.025.

PMID:
20026245
2.

Elevated levels of circulating trace amines in primary headaches.

D'Andrea G, Terrazzino S, Leon A, Fortin D, Perini F, Granella F, Bussone G.

Neurology. 2004 May 25;62(10):1701-5.

PMID:
15159465
3.

Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.

Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ.

Brain. 2007 Jul;130(Pt 7):1847-60.

PMID:
17412733
4.

Study of tyrosine metabolism in eating disorders. Possible correlation with migraine.

D'Andrea G, Ostuzzi R, Bolner A, Francesconi F, Musco F, d'Onofrio F, Colavito D.

Neurol Sci. 2008 May;29 Suppl 1:S88-92. doi: 10.1007/s10072-008-0895-4.

PMID:
18545905
5.

Abnormal platelet trace amine profiles in migraine with and without aura.

D'Andrea G, Granella F, Leone M, Perini F, Farruggio A, Bussone G.

Cephalalgia. 2006 Aug;26(8):968-72.

PMID:
16886933
6.
7.

Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease.

Hegde ML, Shanmugavelu P, Vengamma B, Rao TS, Menon RB, Rao RV, Rao KS.

J Trace Elem Med Biol. 2004;18(2):163-71.

PMID:
15646263
8.

A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.

Llau ME, Durrieu G, Tran MA, Senard JM, Rascol O, Montastruc JL.

Clin Neuropharmacol. 1996 Oct;19(5):420-7.

PMID:
8889285
9.

Analysis of biogenic amines in plasma of hypertensive patients and a control group.

Andrew R, Best SA, Watson DG, Midgley JM, Reid JL, Squire IB.

Neurochem Res. 1993 Nov;18(11):1179-82.

PMID:
8255371
10.

The role of tyrosine metabolism in the pathogenesis of chronic migraine.

D'Andrea G, D'Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, Colavito D, Leon A, Rosteghin V, Perini F.

Cephalalgia. 2013 Aug;33(11):932-7. doi: 10.1177/0333102413480755.

PMID:
23493762
11.

Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.

Rose S, Hindmarsh JG, Steiger MJ, Bhatt M, Quinn NP, Jenner P, Marsden CD.

Clin Neuropharmacol. 1994 Jun;17(3):260-9.

PMID:
9316671
12.

Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.

Nagatsu T, Sawada M.

J Neural Transm Suppl. 2007;(72):113-20. Review.

PMID:
17982884
13.

Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease.

Bharucha KJ, Friedman JK, Vincent AS, Ross ED.

J Neurol. 2008 Dec;255(12):1957-62. doi: 10.1007/s00415-009-0063-7.

PMID:
19159062
14.

Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease.

Shadrina MI, Filatova EV, Karabanov AV, Slominsky PA, Illarioshkin SN, Ivanova-Smolenskaya IA, Limborska SA.

Neurosci Lett. 2010 Apr 12;473(3):257-9. doi: 10.1016/j.neulet.2010.02.061.

PMID:
20193743
15.

The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.

Huot P, Lévesque M, Parent A.

Brain. 2007 Jan;130(Pt 1):222-32.

PMID:
17142832
16.

Plasma levels of inorganic sulfates in patients with Parkinson's disease.

Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Jorge-Santamaría A, Mateos-Vega CJ, González-Muñoz MJ, Cabrera-Valdivia F, Ayuso-Peralta L, Benito J, Vázquez A, et al.

Acta Neurol Scand. 1995 Nov;92(5):369-71.

PMID:
8610488
17.

Serum noradrenaline response to standing up in patients with Parkinson's disease.

Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV.

Eur Neurol. 1986;25(5):355-61.

PMID:
3780779
18.

HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes.

D'Andrea G, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon A.

Neurosci Lett. 2003 Jul 31;346(1-2):89-92.

PMID:
12850555
19.

The relation of testosterone levels with fatigue and apathy in Parkinson's disease.

Kenangil G, Orken DN, Ur E, Forta H, Celik M.

Clin Neurol Neurosurg. 2009 Jun;111(5):412-4. doi: 10.1016/j.clineuro.2008.11.019.

PMID:
19131155
20.

Circulating interleukin-10 and interleukin-12 in Parkinson's disease.

Rentzos M, Nikolaou C, Andreadou E, Paraskevas GP, Rombos A, Zoga M, Tsoutsou A, Boufidou F, Kapaki E, Vassilopoulos D.

Acta Neurol Scand. 2009 May;119(5):332-7. doi: 10.1111/j.1600-0404.2008.01103.x.

PMID:
18976327
Items per page

Supplemental Content

Support Center